Exact Mass: 669.1846166
Exact Mass Matches: 669.1846166
Found 22 metabolites which its exact mass value is equals to given mass value 669.1846166,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Chymosin preparation, escherichia coli k-12
C30H27N3O15 (669.1442112000001)
Chymosin preparation, escherichia coli k-12 is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
N,N,N-tris(2,3-dihydroxybenzoyl)-O-(alpha-aminoacryl)-O-seryl-Serin
C30H27N3O15 (669.1442112000001)
Enterobactin
C30H27N3O15 (669.1442112000001)
A macrotriolide produced by certain members of Enterobacteriaceae, e.g. Escherichia coli and Salmonella. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
Almitrine mesylate
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[2-[(2S,4S)-4-[(2R,3R,4R,5S,6S)-3-fluoro-4,5-dihydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] 3-aminopropanoate,hydrochloride
C30H33ClFNO13 (669.1624370000001)
Berubicin hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Delphinidin 3-glucoside-5-(6-acetylglucoside)
C29H33O18+ (669.1666818000001)
[3,7-bis(4-hydroxy-3,5-dimethoxyphenyl)-4-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium
5-{[(2s,3r,4s,5s,6s)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-3-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
[C29H33O18]+ (669.1666818000001)
{3-hydroxy-23,24-dimethoxy-7,7-dimethyl-5,8,18,27,29-pentaoxo-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaen-10-yl}methyl 3-methylbutanoate
n-[7,11-bis({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino})-2,6,10-trioxo-1,5,9-trioxacyclododecan-3-yl]-2,3-dihydroxybenzenecarboximidic acid
C30H27N3O15 (669.1442112000001)
n-[(3s,7s,11s)-7,11-bis({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino})-2,6,10-trioxo-1,5,9-trioxacyclododecan-3-yl]-2,3-dihydroxybenzenecarboximidic acid
C30H27N3O15 (669.1442112000001)